Should Microvolt T-Wave Alternans Be Utilized Routinely in Selecting Patients for Prophylactic Implantable Cardioverter-Defibrillator Insertion in the Setting of Ischemic Heart Disease?**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 49, Issue 1, 2007, Pages 59-61

  Russo, Andrea M ^a   Marchlinski, Francis E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DEFIBRILLATOR; EDITORIAL; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE VARIABILITY; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HOLTER MONITORING; HUMAN; ISCHEMIC HEART DISEASE; MICROVOLT T WAVE ALTERANS; MORTALITY; PATIENT SELECTION; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROGNOSIS; QRS COMPLEX; QUALITY OF LIFE; REIMBURSEMENT; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SENSITIVITY AND SPECIFICITY; T WAVE;

ARRHYTHMIA; DEFIBRILLATORS, IMPLANTABLE; HUMANS; MYOCARDIAL ISCHEMIA; PROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 33845878255     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.10.008     Document Type: Editorial

References (15)

1. Huikuri H.V., Castellanos A., and Myerburg R.J. Sudden death due to cardiac arrhythmias. N Engl J Med 345 (2001) 1473-1482
2. Buxton A.E. Risk stratification for sudden death: do we need anything more than ejection fraction?. Card Electrophysiol Rev 7 (2003) 434-437
3. Chow T., Kereiakes D.J., Bartone C., et al. Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy. J Am Coll Cardiol 49 (2007) 50-58
4. Rosenbaum D.S., Jackson L.E., Smith J.M., et al. Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med 330 (1994) 235-241
5. Gold M.R., Bloomfield D.M., Anderson K.P., et al. A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification. J Am Coll Cardiol 36 (2000) 2247-2253
6. Gehi A.K., Stein R.H., Metz L.D., and Gomes A. Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: a meta-analysis. J Am Coll Cardiol 46 (2005) 75-82
7. Bloomfield D.M., Bigger J.T., Steinman R.C., et al. Microvolt T wave alternans and risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 47 (2006) 456-463
8. Chow T., Kereiakes D.J., Bartone C., et al. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. J Am Coll Cardiol 47 (2006) 1820-1827
9. Bloomfield D.M., Steinman R.C., Namerow P.B., et al. Microvolt T wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial II conundrum. Circulation 110 (2004) 1885-1889
10. Greenberg H., Case R.B., Moss A.J., et al., MADIT II Investigators. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT II). J Am Coll Cardiol 43 (2004) 1459-1465
11. Bardy G.H., Lee K.L., Mark D.B., et al., SCD-HeFT Investigators. Amiodarone or an implantable cardioverter defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
12. Chan P.S., Stein K., Chow T., et al. Cost-effectiveness of a microvolt T wave alternans screening strategy for implantable cardioverter defibrillator placement in the MADIT II-eligible population. J Am Coll Cardiol 48 (2006) 112-121
13. Nazarian S., Bluemke D.A., Lardo A.C., et al. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 112 (2005) 2821-2825
14. The Antiarrhythmics Versus Implantable Defibrillaors (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337 (1997) 1576-1583
15. Kuck K.H., Cappato R., Siebels J., Ruppel R., and CASH Investigators. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 102 (2000) 748-754